
ONL Therapeutics
Operator of a biopharmaceutical company intended to protect and improve patients' vision with various retinal diseases and conditions. The company develops therapeutics treatments for serious, vision-...
Valuation
$0
Share Price
N/A
Total Raised
$132.5M
Last Round
N/A